AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour levodopa-based subcutaneous ...

Our second ever Global B2B Marketing Agencies Benchmarking Report is back and it is showcasing the best-of-the-best in B2B across the globe, from the UK to the US and beyond. If you're looking for ...